Daniel Virnich's Insider Trades & SAST Disclosures
Daniel Virnich's most recent trade in Oncology Institute Inc (The) was a trade of 1,083,334 Common stock done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel Virnich.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,083,334 | 1,807,697 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 26 Mar 2025 | 22,640 | 724,363 | - | 1.0 | 23,584 | Common Stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2025 | 11,320 | 11,320 | - | - | Common Warrant | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.89 per share. | 19 Mar 2025 | 10,261 | 701,723 | - | 0.9 | 9,122 | Common stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 4,977 | 711,984 | - | 0.1 | 677 | Common stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 4,750 | 716,961 | - | 0.1 | 646 | Common stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 117,142 | 721,711 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 78,094 | 838,853 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 496,293 | 496,293 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 198,517 | 916,947 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.60 per share. | 21 May 2024 | 11,173 | 718,430 | - | 0.6 | 6,673 | Common Stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 4,322 | 729,603 | - | 2.2 | 9,478 | Common stock |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 2.39 per share. | 14 Nov 2023 | 4,604 | 733,925 | - | 2.4 | 10,981 | Common stock |
| Oncology Institute Inc (The) | Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 287,361 | 287,361 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 114,944 | 738,529 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 175,000 | 829,609 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 07 Dec 2022 | 175,000 | 623,585 | - | 0.9 | 150,500 | Common Stock |
| Oncology Institute Inc (The) | Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 07 Dec 2022 | 175,000 | 448,585 | - | 0.9 | 150,500 | Common Stock |
| Oncology Institute Inc (The) | Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 175,000 | 654,609 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 203,543 | 203,543 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 40,101 | 273,585 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Daniel Virnich | President | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 3,767 | 233,484 | - | 2.0 | 7,639 | Common Stock |
| Oncology Institute Inc (The) | Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 213,259 | 213,259 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 578,006 | 68,208 | - | - | Stock Options (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 426,603 | 426,603 | - | - | Stock Options (right to buy) | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 117,142 | 195,236 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 78,094 | 78,094 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges